Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
New study in mice shows gut microbes are a driver of age-associated inflammation
11 May 2017by Andreu Prados
A recent study, led by Dr. Dawn Bowdish from McMaster University in Hamilton (Canada) has found that gut microbes are a driver of age-associated inflammation in mice.
Gut bacteria are involved in modulating immune responses in patients with ankylosing spondylitis
4 May 2017by Andreu Prados
A recent study has found that gut dysbiosis in AS patients is associated with intestinal mucosal barrier dysfunction and modulation of both local and systemic immune responses.
The impact of dietary emulsifiers on gut microbiota and gut barrier function
17 Aug 2015by Patrice D. Cani
A recent study (Chassaing, et al.) showed that two dietary emulsifiers -- carboxymethylcellulose and polysorbate-80 -- induced gut microbiota alteration and gut barrier dysfunction in mice, resulting in weight gain, low-grade inflammation, and metabolic disorders.
Bernd Schnabl, on incorporating intestinal microbiota into the leaky gut hypothesis of liver disease
3 Jul 2015by Kristina Campbell
Bernd Schnabl, MD, is a practicing physician and associate professor at University of California San Diego. His research focuses on the cellular and molecular mechanisms that contribute to chronic liver disease.
Not the usual probiotic suspect: Research shows Lactococcus lactis has anti-inflammatory effects in mice
8 Jun 2015by Kristina Campbell
Results of a research collaboration between Harvard and Danone, released today, show that an 'underrated' species of bacteria, Lactococcus lactis CNCM I-1631, conferred beneficial effects in mouse models of inflammation.
Dr. Justin Sonnenburg: Gut inflammatory trajectories and treatment of chronic disease
8 Jun 2015by GMFH Editing Team
Dr. Justin Sonnenburg, of Stanford University, is carrying out exciting research in the area of host-microbiota interactions. He is also the co-author of a popular book called "The Good Gut".
Dr. Patrice Cani: The vicious cycle of gut permeability and inflammation
3 Jun 2015by GMFH Editing Team
Dr. Patrice Cani, from Catholic University of Louvain, is a leading researcher in the area of gut microbiota and metabolic disorders. He serves on the Gut Microbiota for Health board of experts.
Akkermansia muciniphila and Faecalibacterium prausnitzii differentially affect host transcriptional response: focus on a powerful tool to study host-microbe interactions
21 Aug 2014by Patrice D. Cani
Numerous commensal bacteria present in the gut microbiota produce short chain fatty acids (SCFA’s) particularly acetate, butyrate and propionate. These SCFA’s have been associated with several biological effects upon host. Growing evidence suggests that specific microbes such as Faecalibacterium prausnitzii
Scientists from Brussels University noticed recently in a recent published article that enterotypes could be found also in mice model whatever the genetic background. Although genetic and environmental factor have to be taken in account during any experiment with mice,